An Hsu

467 total citations
7 papers, 369 citations indexed

About

An Hsu is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, An Hsu has authored 7 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Cancer Research and 2 papers in Molecular Biology. Recurrent topics in An Hsu's work include Colorectal Cancer Treatments and Studies (2 papers), Genetic factors in colorectal cancer (2 papers) and Cancer-related Molecular Pathways (2 papers). An Hsu is often cited by papers focused on Colorectal Cancer Treatments and Studies (2 papers), Genetic factors in colorectal cancer (2 papers) and Cancer-related Molecular Pathways (2 papers). An Hsu collaborates with scholars based in Taiwan and United States. An Hsu's co-authors include Hua‐Chien Chen, Shu‐Jen Chen, Yu‐Sun Chang, Pao‐Hsien Chu, Hung‐Chih Hsu, Chien Yuh Yeh, Wen‐Sy Tsai, Chi‐Neu Tsai, Tsai‐Sheng Yang and Yen‐Jung Lu and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and American Journal of Transplantation.

In The Last Decade

An Hsu

7 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
An Hsu Taiwan 6 136 135 116 82 75 7 369
Gyula Végső Hungary 11 22 0.2× 67 0.5× 222 1.9× 75 0.9× 81 1.1× 28 379
Ozan Salim Türkiye 11 12 0.1× 44 0.3× 52 0.4× 29 0.4× 35 0.5× 46 271
Amit Pande United States 6 23 0.2× 76 0.6× 105 0.9× 22 0.3× 133 1.8× 27 234
L.L. Siu Canada 7 35 0.3× 140 1.0× 176 1.5× 12 0.1× 171 2.3× 21 438
Kirk Heyne United States 8 64 0.5× 104 0.8× 311 2.7× 13 0.2× 278 3.7× 19 537
Timothy H.T. Cheng Hong Kong 7 377 2.8× 266 2.0× 96 0.8× 8 0.1× 74 1.0× 8 438
Ting‐Jung Wu Taiwan 11 64 0.5× 82 0.6× 94 0.8× 9 0.1× 113 1.5× 21 359
Yingcheng Lin China 9 50 0.4× 90 0.7× 191 1.6× 2 0.0× 62 0.8× 32 436
M.-C. Pujazon France 9 171 1.3× 102 0.8× 110 0.9× 5 0.1× 29 0.4× 22 392
R Rajaganeshan United Kingdom 11 64 0.5× 71 0.5× 147 1.3× 37 0.5× 163 2.2× 23 333

Countries citing papers authored by An Hsu

Since Specialization
Citations

This map shows the geographic impact of An Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by An Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites An Hsu more than expected).

Fields of papers citing papers by An Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by An Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by An Hsu. The network helps show where An Hsu may publish in the future.

Co-authorship network of co-authors of An Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of An Hsu. A scholar is included among the top collaborators of An Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with An Hsu. An Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Chen, Ming-Jer, An Hsu, Pei‐Yi Lin, et al.. (2023). Development of a Predictive Model for Optimization of Embryo Transfer Timing Using Blood-Based microRNA Expression Profile. International Journal of Molecular Sciences. 25(1). 76–76. 5 indexed citations
2.
Hsu, Hung‐Chih, Chuang‐Wei Wang, Pei‐Yi Lin, et al.. (2018). Targeted Sequencing of Circulating Tumor DNA to Monitor Genetic Variants and Therapeutic Response in Metastatic Colorectal Cancer. Molecular Cancer Therapeutics. 17(10). 2238–2247. 24 indexed citations
3.
Hsu, Hung‐Chih, Yen‐Jung Lu, Chien Yuh Yeh, et al.. (2016). Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients. Oncotarget. 7(16). 22257–22270. 97 indexed citations
4.
Chao, Angel, et al.. (2015). BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer. PLoS ONE. 10(7). e0133081–e0133081. 29 indexed citations
5.
Orandi, Babak J., Eric K.H. Chow, An Hsu, et al.. (2015). Quantifying Renal Allograft Loss Following Early Antibody-Mediated Rejection. American Journal of Transplantation. 15(2). 489–498. 85 indexed citations
6.
Chen, Shu‐Jen, Hsuan Liu, Chun‐Ta Liao, et al.. (2015). Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature. Oncotarget. 6(20). 18066–18080. 49 indexed citations
7.
Hsu, An, Shu‐Jen Chen, Yu‐Sun Chang, Hua‐Chien Chen, & Pao‐Hsien Chu. (2014). Systemic Approach to Identify Serum microRNAs as Potential Biomarkers for Acute Myocardial Infarction. BioMed Research International. 2014. 1–13. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026